Madeleine Farman
Madeleine Farman is a senior reporter for PEI Group’s Private Equity International and Secondaries Investor titles, based in London. Prior to joining PEI, she had covered private equity, private capital and advisers associated with the industry for other newsrooms and publications since 2016. Originally from New Zealand, Madeleine began her career in radio in Auckland.
One-third of respondents to Secondaries Investor‘s latest survey of intermediaries say they worked with another adviser on a transaction during the reporting period.
There are some sizeable LP-led portfolios out in the market. However, one LP believes collateralised fund obligations and NAV loans could provide attractive alternatives to traditional portfolio sales.
Hamilton Lane Secondary Fund VI launched in 2021 with a $5bn target and is more than 40% larger than its predecessor.
The pension giant is understood to be looking to offload LP stakes valued between $2bn and just over $3bn.
GP-led market could grow to as much as $500bn 'effortlessly', AltamarCAM chief executive José Luis Molina tells Secondaries Investor.
Private equity secondaries will be a $500bn market by 2030, the firm's founder and chief investment officer Jeremy Coller tells Secondaries Investor.
The European buyout firm moved Sunrise Medical into a landmark €2.5bn multi-asset continuation vehicle six years ago.
Crown Secondaries Special Opportunities III has closed on $3bn ahead of its $2.5bn target.
Predecessor vehicle Fund IV is over 75% invested and has a TVPI of 1.5x, according to documents prepared for a US state investor.
Amid the broadening supply of private wealth-focused evergreen vehicles, ICG and Dawson Partners are the latest managers to join the fold with funds focused on secondaries.